Lilly Diabetes Donates 91 Scholarships to American Diabetes Association's Summer Camp Program - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Lilly Diabetes Donates 91 Scholarships to American Diabetes Association's Summer Camp Program

PTSM: Pharmaceutical Technology Sourcing and Management
Volume 10, Issue 3
Lilly Diabetes announced its support for the American Diabetes Association's summer camp program for the seventh year in a row with a donation of $91,000 that will send 91 children to diabetes camp this summer. Since 2008, Lilly Diabetes has supported 531 children attending diabetes camps throughout the US, a scholarship donation totaling over half a million dollars.

Today, there are approximately 130 diabetes camps nationwide. The Association is the single largest operator of US camps for children with diabetes, with 40 camps offering 49 sessions in 25 states each summer. In the last decade, Lilly has donated more than $20 million in insulin and other diabetes medicines, educational materials, volunteers, scholarships, and motivational speakers, making it one of the largest supporters of diabetes camps in the country.

Camp scholarships are awarded by the Association based on financial need.

Source: Lilly Diabetes

ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
What role should the US government play in the current Ebola outbreak?
Finance development of drugs to treat/prevent disease.
Oversee medical treatment of patients in the US.
Provide treatment for patients globally.
All of the above.
No government involvement in patient treatment or drug development.
Finance development of drugs to treat/prevent disease.
23%
Oversee medical treatment of patients in the US.
14%
Provide treatment for patients globally.
7%
All of the above.
47%
No government involvement in patient treatment or drug development.
9%
Jim Miller Outsourcing Outlook Jim MillerOutside Looking In
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerAdvances in Large-Scale Heterocyclic Synthesis
Jill Wechsler Regulatory Watch Jill Wechsler New Era for Generic Drugs
Sean Milmo European Regulatory WatchSean MilmoTackling Drug Shortages
New Congress to Tackle Health Reform, Biomedical Innovation, Tax Policy
Combination Products Challenge Biopharma Manufacturers
Seven Steps to Solving Tabletting and Tooling ProblemsStep 1: Clean
Legislators Urge Added Incentives for Ebola Drug Development
FDA Reorganization to Promote Drug Quality
Source: PTSM: Pharmaceutical Technology Sourcing and Management,
Click here